FDA Inspection 883463 — Lingraphicare America, Inc.

Lingraphicare America, Inc. — FEI 1000123978

The FDA completed an inspection of Lingraphicare America, Inc. on Jun 24, 2014 in Princeton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 3 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 24, 2014
Fiscal Year
2014
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Princeton, NJ (United States)

Citations

IDCFRDescription
1471621 CFR 820.30(f)Design verification - output does not meet input requirement
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
367721 CFR 820.30(g)Design validation - software validation not performed

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.